logo

For the Inventor, By the Inventor

Marburg, Germany

Hans-Ulrich Schorlemmer

This inventor holds 9 USPTO granted patents. Top assignees: Hoechst Aktiengesellschaft, Behringwerke Aktiengesellschaft, Laboratoires Hoechst. Active years: 1986-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Ulrich Schorlemmer. Retrieved from https://idiyas.com/inventor/hans-ulrich-schorlemmer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 94(Granted Patents)


Location History:

  • Weimar, DE (1986 - 1987)
  • Marburg, DE (1988 - 1998)
  • Marburg-Dagobertshausen, DE (1998)

Company Filing History:

goldMedal5 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents
silverMedal4 out of 340 
 
Behringwerke Aktiengesellschaft
 patents
bronzeMedal1 out of 1 
 
Laboratoires Hoechst
 patent
where one patent can have more than one assignee

Years Active: 1986-1998

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5849799 - Use of deoxyspergualin for preparing a pharmaceutical for treating (1998-12-15),
2. 5780592 - Compositions comprising lipoproteins and crotonamide derivatives (1998-07-14),
3. 5561119 - Glycosylated prodrugs, their method of preparation and their uses (1996-10-01),
4. 4847299 - Use of 15-deoxyspergualine as a pharmaceutical (1989-07-11),
5. 4762848 - 1,3-thiazoles and their use as immunomodulators (1988-08-09),
6. 4701452 - Use of cephem compounds as immunomodulators (1987-10-20),
7. 4699912 - Use of Lycorine as an immunosuppressor (1987-10-13),
8. 4603137 - Immunosuppressive chromone alkaloid (1986-07-29),
9. 4578399 - Use of the diterpene derivative forskolin for immunostimulation (1986-03-25),

Title: The Innovations of Hans-Ulrich Schorlemmer

Introduction

Hans-Ulrich Schorlemmer is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory diseases and immunological disorders. With a total of 9 patents to his name, Schorlemmer's work has had a profound impact on medical science.

Latest Patents

Among his latest patents is the use of deoxyspergualin for preparing a pharmaceutical aimed at treating hyperreactive inflammatory diseases in both humans and animals. This method involves administering a pharmaceutically effective amount of deoxyspergualin. Another significant patent involves compositions comprising lipoproteins and crotonamide derivatives, which are suitable for treating immunological disorders, cancer, or in transplantation.

Career Highlights

Schorlemmer has worked with prominent companies such as Hoechst Aktiengesellschaft and Behringwerke Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Gerhard Dickneite and Hans-Harald Sedlacek. Their collaborative efforts have contributed to the advancement of research and development in their respective fields.

Conclusion

Hans-Ulrich Schorlemmer's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through scientific research. His patents and collaborations reflect a career dedicated to addressing critical medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…